The International Society for Stem Cell Research ( ISSCR ) has appointed University of Cape Town’s (UCT) Dr Mubeen Goolam as one of the three new Goldstein Science Policy Fellows.

The REVIVE trial is one of the largest ever HIV trials to take place on the continent – testing a simple antibiotic intervention with the potential to increase survival rates in advanced HIV.

UCT sees an improvement in subject placement according to the THE World University Rankings published this month.

UCT’s Professor in Infectious Diseases at Imperial and the Director of the Wellcome Discovery Research Platform for Infection has been awarded an OBE in the New Year Honours List.

The fight against HIV has reached a historic milestone with Science naming Lenacapavir its 2024 Breakthrough of the Year .